Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway
[Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts in...
Saved in:
Published in | Cytokine (Philadelphia, Pa.) Vol. 184; p. 156771 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.12.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells’ proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART. |
---|---|
AbstractList | The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART.The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART. The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells' proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART. [Display omitted] The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types. Ang-1 has been shown to promote the progression of glioma, glioma, esophageal and human cervical cancer, whereas it exerts inhibitory effects on the growth of breast and colon cancer. However, the specific function of Ang-1 in CM has not been clarified. This research aims to explore the function of Ang-1 on CM and the underlying mechanism. WB and qPCR were utilized to measure the expression levels of different factors in CM cells. Clonogenic, CCK-8 and Transwell migration assay were used to probe CM cells’ proliferation and migration ability. Xenograft tumor model was used to testify the effect of Ang-1 and Artesunate (ART) on the growth of CM in vivo. We found Ang-1 promoted CM proliferation and migration, while it was inhibited by ART in vitro. Moreover, both ART treatment and Ang-1 knockdown had the effect of suppressing tumor growth in CM xenograft model. Mechanically, Ang-1 activated Akt/mTOR pathway and induced epithelial-mesenchymal transition (EMT) in CM cells. Furthermore, ART regulated Akt/mTOR pathway by decreasing the expression of Ang-1 in CM cells. Ang-1 promotes tumorigenesis of CM by regulating Akt/mTOR pathway, which can be inhibited by ART. |
ArticleNumber | 156771 |
Author | Wang, Haowen Lei, Ke Yao, Ningning Gao, Xiaodi Sui, Aihua Luo, Wenjuan Yi, Wendan Liu, Yichong Zhao, Xintong Zhang, Qian Ma, Qingyue |
Author_xml | – sequence: 1 givenname: Ningning surname: Yao fullname: Yao, Ningning organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 2 givenname: Qingyue surname: Ma fullname: Ma, Qingyue organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 3 givenname: Wendan surname: Yi fullname: Yi, Wendan organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 4 givenname: Yichong surname: Liu fullname: Liu, Yichong organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 5 givenname: Qian surname: Zhang fullname: Zhang, Qian organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 6 givenname: Xiaodi surname: Gao fullname: Gao, Xiaodi organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 7 givenname: Xintong surname: Zhao fullname: Zhao, Xintong organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 8 givenname: Haowen surname: Wang fullname: Wang, Haowen organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 9 givenname: Ke surname: Lei fullname: Lei, Ke organization: Tumor Immunology and Cytotherapy of Medical Research Center and Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), The Affiliated Hospital of Qingdao University, Qingdao 266000, China – sequence: 10 givenname: Aihua surname: Sui fullname: Sui, Aihua organization: Center Laboratory, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China – sequence: 11 givenname: Wenjuan surname: Luo fullname: Luo, Wenjuan email: luowenjuan@qdu.edu.cn organization: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, 266003, Qingdao, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39340959$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctuGyEYRlGVqkncvkAXFctuxoFhLkHqxrLSJFKkSJW7Rgz8jHFnwAUmkV-kzxvGTjZdZMXtHATfd4nOnHeA0FdKlpTQ5mq3VIfklyUpqyWtm7alH9AFJbwpCCnZ2TyvWFE1TXOOLmPcEUI4a9tP6JxxVhFe8wv0b-X6guJ98KNPEHGaRh9sDw6ijVg6jUfQVh6PtpA3ki2UdAoCBmNApYi9wauQgcllDHuH11sfvNVyyO4gnR8lfrLy6Afop0Emm6lZ-5Ouxs3jLxxt7-RgXY_3Mm2f5eEz-mjkEOHL67hAv3_ebNZ3xcPj7f169VAoVjep0IwbTqq6rDiRTNPGcOioqY0GySjTHWm5ulZ5YWrSmfx7poGVvIO6NFx2bIG-n-7NAfydICYx2qhgyM8GP0XBaM6TljVpM_rtFZ26nInYBzvKcBBvWWbg-gSo4GMMYISy6fjXFKQdBCVirk3sxFybmGsTp9qyWv6nvt3-rvTjJEEO6MlCEFFZyNVoG3IxQnv7nv4C8GOz0Q |
CitedBy_id | crossref_primary_10_3389_fphar_2024_1483049 |
Cites_doi | 10.1016/S0002-9440(10)63998-3 10.3892/ijo.2021.5190 10.1016/j.preteyeres.2018.03.004 10.1080/21655979.2020.1834727 10.1016/j.gene.2020.145134 10.3390/ijms20051164 10.18632/oncotarget.6981 10.3390/molecules22081272 10.1016/j.ophtha.2016.01.023 10.1002/ijc.33381 10.1016/j.preteyeres.2019.100800 10.1093/cid/ciz206 10.1054/bjoc.2000.1437 10.3390/cancers13225730 10.1139/bcb-2021-0275 10.1007/s00706-021-02759-x 10.1038/s41401-020-0395-5 10.1111/jcmm.14717 10.3389/fonc.2021.714646 10.1016/j.leukres.2017.05.007 10.1046/j.1469-7580.2002.00061.x 10.2174/1568009618666180425142653 10.2147/OPTH.S89591 10.1155/2021/9911537 10.1172/JCI4891 10.1016/S0002-9440(10)63413-X 10.1006/excr.2002.5597 10.1007/s12185-010-0697-3 10.1038/s41419-023-05712-4 10.1016/S0002-9440(10)62565-5 10.1016/j.yexmp.2019.01.006 10.1186/s12943-019-1030-2 10.1038/s41598-017-00079-x 10.1080/21655979.2022.2042141 10.3748/wjg.14.1575 10.3390/ijms21249651 10.1016/j.semcancer.2019.07.009 10.1002/jcb.27889 10.1007/978-94-007-6627-3_46 10.1016/j.neo.2017.02.002 10.1016/j.cell.2010.06.011 |
ContentType | Journal Article |
Copyright | 2024 Elsevier Ltd Copyright © 2024 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2024 Elsevier Ltd – notice: Copyright © 2024 Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.cyto.2024.156771 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1096-0023 |
ExternalDocumentID | 39340959 10_1016_j_cyto_2024_156771 S1043466624002758 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29F 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABBQC ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABMZM ABOCM ABUDA ABXDB ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFJKZ AFKWA AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HLW HMG HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LG5 LUGTX LX2 LZ5 M29 M41 MO0 N9A O-L O9- OAUVE OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SBG SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSU SSZ T5K TEORI UNMZH WUQ XPP ZMT ~G- AATTM AAYWO AAYXX ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP ANKPU APXCP CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c356t-d39f90452490a3d16f9eb1f5fdea313db079c8cea3f50bf9373de329be52f9ab3 |
IEDL.DBID | .~1 |
ISSN | 1043-4666 1096-0023 |
IngestDate | Fri Jul 11 00:17:15 EDT 2025 Wed Feb 19 02:03:00 EST 2025 Tue Jul 01 03:32:33 EDT 2025 Thu Apr 24 22:58:52 EDT 2025 Sat Nov 23 15:54:46 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Epithelial-mesenchymal transition Ang-1 Choroidal melanoma Akt/mTOR Artesunate |
Language | English |
License | Copyright © 2024 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c356t-d39f90452490a3d16f9eb1f5fdea313db079c8cea3f50bf9373de329be52f9ab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 39340959 |
PQID | 3110912507 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3110912507 pubmed_primary_39340959 crossref_citationtrail_10_1016_j_cyto_2024_156771 crossref_primary_10_1016_j_cyto_2024_156771 elsevier_sciencedirect_doi_10_1016_j_cyto_2024_156771 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2024 2024-12-00 2024-Dec 20241201 |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: December 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Cytokine (Philadelphia, Pa.) |
PublicationTitleAlternate | Cytokine |
PublicationYear | 2024 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Farhan, Silva, Xingan, Zhou, Zheng (b0130) 2021; 2021 Li, Guan, Liu, Liu, Song, Zhang, Zhao, Zhou, Gao (b0180) 2023; 14 Thurston (b0050) 2002; 200 Huang, Gan, Zhuang, Chen, Lu, Wang, Qi, Feng, Huang, Du, Zhang, Liu (b0110) 2022; 11 Li, Ma, Deng, Wu, Wang, Zhou (b0125) 2021; 766 Shim, Teh, Bapna, Kim, Koh, Mack, Ge (b0070) 2002; 279 Wang, Wang, Lu, Zhang, Liu, Zhou, Dai, Zheng (b0225) 2020; 11 Xu, Liu, Zhuang (b0190) 2022; 100 Yang, Zheng, Zhan, Fan (b0210) 2019; 11 Tanaka, Mori, Sakamoto, Makuuchi, Sugimachi, Wands (b0170) 1999; 103 Wei, Liu, Chen, Yin, Liu, Ouyang, Zeng, Nie, Chen (b0195) 2020; 24 Asnaghi, Gezgin, Tripathy, Handa, Merbs, van der Velden, Jager, Harbour, Eberhart (b0240) 2015; 21 Duran, Borriello, Karagiannis, Entenberg, Oktay, Condeelis (b0040) 2021; 13 Yao, Zhao, Yin, Wang, Gao (b0095) 2020; 41 Ye, Li, Li, Chang, Zhang (b0155) 2018; 15 Fallico, Raciti, Longo, Reibaldi, Bonfiglio, Russo, Caltabiano, Gattuso, Falzone, Avitabile (b0015) 2021; 58 Tang, Liu, Russell, Clements, Ling (b0030) 2019; 20 Smit, Jager, de Klein, Kiliҫ (b0020) 2020; 75 Lemmon, Schlessinger (b0150) 2010; 141 Damato (b0010) 2018; 66 Hawighorst, Skobe, Streit, Hong, Velasco, Brown, Riccardi, Lange-Asschenfeldt, Detmar (b0085) 2002; 160 Chen, Wong, Lim, Lim, Lin, Wang, Hua (b0200) 2017; 22 Chen, Liu, Mao, Tan, Mo, Meng, Cao, Zhong, Liu, Shan, Jiang (b0215) 2019; 18 Machein, Knedla, Knoth, Wagner, Neuschl, Plate (b0065) 2004; 165 Chen, Lu, Montoya-Durango, Liu, Dean, Darling, Kaplan, Dean, Gao, Liu (b0220) 2017; 7 Naumnik, Naumnik, Niewiarowska, Ossolinska, Chyczewska (b0060) 2013; 788 Yavuzyigitoglu, Koopmans, Verdijk, Vaarwater, Eussen, van Bodegom, Paridaens, Kiliç, de Klein (b0025) 2016; 123 Xue, Sheng, Duan, Yang, Ma, Xu, Wei, Shang, Li, Wan, Qin (b0035) 2021; 148 Liu, Bai, Yuan, Gong, Huang (b0045) 2008; 14 El Ket, Kendjo, Thellier, Assoumou, Potard, Taieb, Tantaoui, Caumes, Piarroux, Roussel, Buffet, Costagliola, Jauréguiberry (b0090) 2020; 70 Nunes, Pandey, Yadav, Goel, Ateeq (b0135) 2017; 19 Jing, Dong, Min, Runpeng, Xuewei, Ru, Yingru, Shengfa, Baoxian, Jinbo, Weidong, Rongbo (b0230) 2019; 120 Khanal (b0120) 2021; 152 Zheng, Pan (b0140) 2018; 18 Stoeltzing, Ahmad, Liu, McCarty, Wey, Parikh, Fan, Reinmuth, Kawaguchi, Bucana, Ellis (b0080) 2003; 63 Chen, Zeng, Kleibeuker, Buffa, Barberis, Leek, Roxanis, Zhang, Worth, Beech, Harris, Cai (b0055) 2016; 7 Greenshields, Fernando, Hoskin (b0105) 2019; 107 Soltysova, Sedlackova, Dvorska, Jasek, Chokhachi Baradaran, Horvathova Kajabova, Demkova, Buocikova, Kurucova, Lyskova, Furdova, Minarik, Babal, Dankova, Smolkova (b0235) 2020; 21 Krantz, Dave, Komatsubara, Marr, Carvajal (b0005) 2017; 11 Tian, Smit, Jücker (b0175) 2023; 24 Yu, Stamenkovic (b0165) 2001; 158 Hayes, Huang, Yu, Maisonpierre, Liu, Kern, Lippman, McLeskey, Li (b0075) 2000; 83 Hu, Ni, Teng (b0100) 2022; 13 Alzahrani (b0145) 2019; 59 Aoki, Fujishita (b0185) 2017; 407 Chen, Shi, Yang, Li, Guo, Pan (b0160) 2010; 92 Geng, Zhu, Yuan, Bai, Dou, Sui, Luo (b0115) 2021; 11 Kumar, Kalvala, Chu, Rosen, Forman, Marcucci, Chen, Pullarkat (b0205) 2017; 59 Machein (10.1016/j.cyto.2024.156771_b0065) 2004; 165 Shim (10.1016/j.cyto.2024.156771_b0070) 2002; 279 Lemmon (10.1016/j.cyto.2024.156771_b0150) 2010; 141 Li (10.1016/j.cyto.2024.156771_b0180) 2023; 14 Alzahrani (10.1016/j.cyto.2024.156771_b0145) 2019; 59 Smit (10.1016/j.cyto.2024.156771_b0020) 2020; 75 Greenshields (10.1016/j.cyto.2024.156771_b0105) 2019; 107 Li (10.1016/j.cyto.2024.156771_b0125) 2021; 766 Chen (10.1016/j.cyto.2024.156771_b0220) 2017; 7 Fallico (10.1016/j.cyto.2024.156771_b0015) 2021; 58 Tang (10.1016/j.cyto.2024.156771_b0030) 2019; 20 Naumnik (10.1016/j.cyto.2024.156771_b0060) 2013; 788 Nunes (10.1016/j.cyto.2024.156771_b0135) 2017; 19 Liu (10.1016/j.cyto.2024.156771_b0045) 2008; 14 Hawighorst (10.1016/j.cyto.2024.156771_b0085) 2002; 160 Krantz (10.1016/j.cyto.2024.156771_b0005) 2017; 11 Chen (10.1016/j.cyto.2024.156771_b0200) 2017; 22 Wei (10.1016/j.cyto.2024.156771_b0195) 2020; 24 Kumar (10.1016/j.cyto.2024.156771_b0205) 2017; 59 Aoki (10.1016/j.cyto.2024.156771_b0185) 2017; 407 Geng (10.1016/j.cyto.2024.156771_b0115) 2021; 11 Yao (10.1016/j.cyto.2024.156771_b0095) 2020; 41 Asnaghi (10.1016/j.cyto.2024.156771_b0240) 2015; 21 Ye (10.1016/j.cyto.2024.156771_b0155) 2018; 15 Tian (10.1016/j.cyto.2024.156771_b0175) 2023; 24 Duran (10.1016/j.cyto.2024.156771_b0040) 2021; 13 Khanal (10.1016/j.cyto.2024.156771_b0120) 2021; 152 Zheng (10.1016/j.cyto.2024.156771_b0140) 2018; 18 Yavuzyigitoglu (10.1016/j.cyto.2024.156771_b0025) 2016; 123 El Ket (10.1016/j.cyto.2024.156771_b0090) 2020; 70 Wang (10.1016/j.cyto.2024.156771_b0225) 2020; 11 Chen (10.1016/j.cyto.2024.156771_b0055) 2016; 7 Stoeltzing (10.1016/j.cyto.2024.156771_b0080) 2003; 63 Yang (10.1016/j.cyto.2024.156771_b0210) 2019; 11 Damato (10.1016/j.cyto.2024.156771_b0010) 2018; 66 Soltysova (10.1016/j.cyto.2024.156771_b0235) 2020; 21 Chen (10.1016/j.cyto.2024.156771_b0160) 2010; 92 Xu (10.1016/j.cyto.2024.156771_b0190) 2022; 100 Tanaka (10.1016/j.cyto.2024.156771_b0170) 1999; 103 Hayes (10.1016/j.cyto.2024.156771_b0075) 2000; 83 Farhan (10.1016/j.cyto.2024.156771_b0130) 2021; 2021 Yu (10.1016/j.cyto.2024.156771_b0165) 2001; 158 Huang (10.1016/j.cyto.2024.156771_b0110) 2022; 11 Chen (10.1016/j.cyto.2024.156771_b0215) 2019; 18 Jing (10.1016/j.cyto.2024.156771_b0230) 2019; 120 Xue (10.1016/j.cyto.2024.156771_b0035) 2021; 148 Thurston (10.1016/j.cyto.2024.156771_b0050) 2002; 200 Hu (10.1016/j.cyto.2024.156771_b0100) 2022; 13 |
References_xml | – volume: 83 start-page: 1154 year: 2000 end-page: 1160 ident: b0075 article-title: Expression and function of angiopoietin-1 in breast cancer publication-title: Br. J. Cancer – volume: 11 start-page: 279 year: 2017 end-page: 289 ident: b0005 article-title: Uveal melanoma: epidemiology, etiology, and treatment of primary disease publication-title: Clinical Ophthalmology (auckland, NZ) – volume: 160 start-page: 1381 year: 2002 end-page: 1392 ident: b0085 article-title: Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth publication-title: Am. J. Pathol. – volume: 75 year: 2020 ident: b0020 article-title: Uveal melanoma: Towards a molecular understanding publication-title: Prog Retin Eye Res – volume: 14 start-page: 1575 year: 2008 end-page: 1581 ident: b0045 article-title: Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer publication-title: World J. Gastroenterol. – volume: 141 start-page: 1117 year: 2010 end-page: 1134 ident: b0150 article-title: Cell signaling by receptor tyrosine kinases publication-title: Cell – volume: 11 start-page: 5301 year: 2019 end-page: 5312 ident: b0210 article-title: An emerging tumor invasion mechanism about the collective cell migration publication-title: Am. J. Transl. Res. – volume: 59 start-page: 125 year: 2019 end-page: 132 ident: b0145 article-title: PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside publication-title: Semin. Cancer Biol. – volume: 158 start-page: 563 year: 2001 end-page: 570 ident: b0165 article-title: Angiopoietin-2 is implicated in the regulation of tumor angiogenesis publication-title: Am. J. Pathol. – volume: 120 start-page: 6026 year: 2019 end-page: 6034 ident: b0230 article-title: Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma publication-title: J Cell Biochem – volume: 63 start-page: 3370 year: 2003 end-page: 3377 ident: b0080 article-title: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors publication-title: Cancer Res. – volume: 20 year: 2019 ident: b0030 article-title: Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway publication-title: Int J Mol Sci – volume: 11 year: 2021 ident: b0115 article-title: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis publication-title: Front Oncol – volume: 41 start-page: 1609 year: 2020 end-page: 1620 ident: b0095 article-title: Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells publication-title: Acta Pharmacol. Sin. – volume: 13 start-page: 6590 year: 2022 end-page: 6599 ident: b0100 article-title: Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism publication-title: Bioengineered – volume: 70 start-page: 280 year: 2020 end-page: 287 ident: b0090 article-title: Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France publication-title: Clin. Infect. Dis. – volume: 19 start-page: 333 year: 2017 end-page: 345 ident: b0135 article-title: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens publication-title: Neoplasia (new York, NY) – volume: 152 start-page: 387 year: 2021 end-page: 400 ident: b0120 article-title: Antimalarial and anticancer properties of artesunate and other artemisinins: current development publication-title: Monatsh. Chem. – volume: 200 start-page: 575 year: 2002 end-page: 580 ident: b0050 article-title: Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage publication-title: J. Anat. – volume: 103 start-page: 341 year: 1999 end-page: 345 ident: b0170 article-title: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma publication-title: J Clin Invest – volume: 407 start-page: 153 year: 2017 end-page: 189 ident: b0185 article-title: Oncogenic Roles of the PI3K/AKT/mTOR Axis publication-title: Curr. Top. Microbiol. Immunol. – volume: 165 start-page: 1557 year: 2004 end-page: 1570 ident: b0065 article-title: Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model publication-title: Am. J. Pathol. – volume: 766 year: 2021 ident: b0125 article-title: Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway publication-title: Gene – volume: 123 start-page: 1118 year: 2016 end-page: 1128 ident: b0025 article-title: Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases publication-title: Ophthalmology – volume: 7 start-page: 45 year: 2017 ident: b0220 article-title: ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression publication-title: Sci Rep – volume: 13 year: 2021 ident: b0040 article-title: Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination publication-title: Cancers (basel) – volume: 107 start-page: 10 year: 2019 end-page: 22 ident: b0105 article-title: The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells publication-title: Exp Mol Pathol – volume: 21 year: 2020 ident: b0235 article-title: Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy publication-title: Int J Mol Sci – volume: 7 start-page: 9353 year: 2016 end-page: 9367 ident: b0055 article-title: Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth publication-title: Oncotarget – volume: 14 start-page: 188 year: 2023 ident: b0180 article-title: PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway publication-title: Cell Death Dis. – volume: 22 year: 2017 ident: b0200 article-title: Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway publication-title: Molecules – volume: 2021 start-page: 9911537 year: 2021 ident: b0130 article-title: Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway publication-title: Oxid. Med. Cell. Longev. – volume: 148 start-page: 1519 year: 2021 end-page: 1528 ident: b0035 article-title: Tie2-expressing monocytes as a novel angiogenesis-related cellular biomarker for non-small cell lung cancer publication-title: Int. J. Cancer – volume: 788 start-page: 341 year: 2013 end-page: 348 ident: b0060 article-title: Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study publication-title: Adv. Exp. Med. Biol. – volume: 58 year: 2021 ident: b0015 article-title: Current molecular and clinical insights into uveal melanoma (Review) publication-title: Int. J. Oncol. – volume: 92 start-page: 587 year: 2010 end-page: 597 ident: b0160 article-title: Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells publication-title: Int. J. Hematol. – volume: 11 start-page: 1197 year: 2020 end-page: 1207 ident: b0225 article-title: Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7 publication-title: Bioengineered – volume: 279 start-page: 299 year: 2002 end-page: 309 ident: b0070 article-title: Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice publication-title: Exp. Cell Res. – volume: 24 year: 2023 ident: b0175 article-title: The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism publication-title: Int J Mol Sci – volume: 66 start-page: 187 year: 2018 end-page: 199 ident: b0010 article-title: Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view publication-title: Prog Retin Eye Res – volume: 59 start-page: 124 year: 2017 end-page: 135 ident: b0205 article-title: Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia publication-title: Leuk. Res. – volume: 21 start-page: 919 year: 2015 end-page: 929 ident: b0240 article-title: EMT-associated factors promote invasive properties of uveal melanoma cells publication-title: Mol. Vis. – volume: 11 year: 2022 ident: b0110 article-title: Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy publication-title: Cells-Basel – volume: 100 start-page: 85 year: 2022 end-page: 92 ident: b0190 article-title: Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/FKHR pathway publication-title: Biochem Cell Biol – volume: 15 start-page: 1313 year: 2018 end-page: 1318 ident: b0155 article-title: Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway publication-title: Oncol. Lett. – volume: 18 start-page: 101 year: 2019 ident: b0215 article-title: Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy publication-title: Mol Cancer – volume: 18 start-page: 988 year: 2018 end-page: 998 ident: b0140 article-title: The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth publication-title: Migration and Invasion of Uveal Melanoma Cells, Curr Cancer Drug Targets – volume: 24 start-page: 276 year: 2020 end-page: 284 ident: b0195 article-title: Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence publication-title: J. Cell Mol. Med. – volume: 158 start-page: 563 year: 2001 ident: 10.1016/j.cyto.2024.156771_b0165 article-title: Angiopoietin-2 is implicated in the regulation of tumor angiogenesis publication-title: Am. J. Pathol.. doi: 10.1016/S0002-9440(10)63998-3 – volume: 407 start-page: 153 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0185 article-title: Oncogenic Roles of the PI3K/AKT/mTOR Axis publication-title: Curr. Top. Microbiol. Immunol.. – volume: 58 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0015 article-title: Current molecular and clinical insights into uveal melanoma (Review) publication-title: Int. J. Oncol.. doi: 10.3892/ijo.2021.5190 – volume: 66 start-page: 187 year: 2018 ident: 10.1016/j.cyto.2024.156771_b0010 article-title: Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view publication-title: Prog Retin Eye Res. doi: 10.1016/j.preteyeres.2018.03.004 – volume: 11 start-page: 1197 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0225 article-title: Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7 publication-title: Bioengineered. doi: 10.1080/21655979.2020.1834727 – volume: 766 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0125 article-title: Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway publication-title: Gene. doi: 10.1016/j.gene.2020.145134 – volume: 20 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0030 article-title: Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway publication-title: Int J Mol Sci. doi: 10.3390/ijms20051164 – volume: 7 start-page: 9353 year: 2016 ident: 10.1016/j.cyto.2024.156771_b0055 article-title: Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth publication-title: Oncotarget. doi: 10.18632/oncotarget.6981 – volume: 15 start-page: 1313 year: 2018 ident: 10.1016/j.cyto.2024.156771_b0155 article-title: Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway publication-title: Oncol. Lett.. – volume: 21 start-page: 919 year: 2015 ident: 10.1016/j.cyto.2024.156771_b0240 article-title: EMT-associated factors promote invasive properties of uveal melanoma cells publication-title: Mol. Vis.. – volume: 22 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0200 article-title: Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway publication-title: Molecules. doi: 10.3390/molecules22081272 – volume: 123 start-page: 1118 year: 2016 ident: 10.1016/j.cyto.2024.156771_b0025 article-title: Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases publication-title: Ophthalmology. doi: 10.1016/j.ophtha.2016.01.023 – volume: 148 start-page: 1519 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0035 article-title: Tie2-expressing monocytes as a novel angiogenesis-related cellular biomarker for non-small cell lung cancer publication-title: Int. J. Cancer. doi: 10.1002/ijc.33381 – volume: 75 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0020 article-title: Uveal melanoma: Towards a molecular understanding publication-title: Prog Retin Eye Res. doi: 10.1016/j.preteyeres.2019.100800 – volume: 70 start-page: 280 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0090 article-title: Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France publication-title: Clin. Infect. Dis.. doi: 10.1093/cid/ciz206 – volume: 83 start-page: 1154 year: 2000 ident: 10.1016/j.cyto.2024.156771_b0075 article-title: Expression and function of angiopoietin-1 in breast cancer publication-title: Br. J. Cancer. doi: 10.1054/bjoc.2000.1437 – volume: 13 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0040 article-title: Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination publication-title: Cancers (basel). doi: 10.3390/cancers13225730 – volume: 100 start-page: 85 year: 2022 ident: 10.1016/j.cyto.2024.156771_b0190 article-title: Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/FKHR pathway publication-title: Biochem Cell Biol. doi: 10.1139/bcb-2021-0275 – volume: 63 start-page: 3370 year: 2003 ident: 10.1016/j.cyto.2024.156771_b0080 article-title: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors publication-title: Cancer Res.. – volume: 11 year: 2022 ident: 10.1016/j.cyto.2024.156771_b0110 article-title: Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy publication-title: Cells-Basel. – volume: 152 start-page: 387 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0120 article-title: Antimalarial and anticancer properties of artesunate and other artemisinins: current development publication-title: Monatsh. Chem.. doi: 10.1007/s00706-021-02759-x – volume: 41 start-page: 1609 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0095 article-title: Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells publication-title: Acta Pharmacol. Sin.. doi: 10.1038/s41401-020-0395-5 – volume: 24 start-page: 276 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0195 article-title: Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence publication-title: J. Cell Mol. Med.. doi: 10.1111/jcmm.14717 – volume: 11 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0115 article-title: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis publication-title: Front Oncol. doi: 10.3389/fonc.2021.714646 – volume: 59 start-page: 124 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0205 article-title: Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia publication-title: Leuk. Res.. doi: 10.1016/j.leukres.2017.05.007 – volume: 200 start-page: 575 year: 2002 ident: 10.1016/j.cyto.2024.156771_b0050 article-title: Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage publication-title: J. Anat.. doi: 10.1046/j.1469-7580.2002.00061.x – volume: 18 start-page: 988 year: 2018 ident: 10.1016/j.cyto.2024.156771_b0140 article-title: The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth publication-title: Migration and Invasion of Uveal Melanoma Cells, Curr Cancer Drug Targets. doi: 10.2174/1568009618666180425142653 – volume: 11 start-page: 279 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0005 article-title: Uveal melanoma: epidemiology, etiology, and treatment of primary disease publication-title: Clinical Ophthalmology (auckland, NZ). doi: 10.2147/OPTH.S89591 – volume: 24 year: 2023 ident: 10.1016/j.cyto.2024.156771_b0175 article-title: The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism publication-title: Int J Mol Sci. – volume: 2021 start-page: 9911537 year: 2021 ident: 10.1016/j.cyto.2024.156771_b0130 article-title: Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway publication-title: Oxid. Med. Cell. Longev.. doi: 10.1155/2021/9911537 – volume: 103 start-page: 341 year: 1999 ident: 10.1016/j.cyto.2024.156771_b0170 article-title: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma publication-title: J Clin Invest. doi: 10.1172/JCI4891 – volume: 165 start-page: 1557 year: 2004 ident: 10.1016/j.cyto.2024.156771_b0065 article-title: Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model publication-title: Am. J. Pathol.. doi: 10.1016/S0002-9440(10)63413-X – volume: 279 start-page: 299 year: 2002 ident: 10.1016/j.cyto.2024.156771_b0070 article-title: Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice publication-title: Exp. Cell Res.. doi: 10.1006/excr.2002.5597 – volume: 92 start-page: 587 year: 2010 ident: 10.1016/j.cyto.2024.156771_b0160 article-title: Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells publication-title: Int. J. Hematol.. doi: 10.1007/s12185-010-0697-3 – volume: 14 start-page: 188 year: 2023 ident: 10.1016/j.cyto.2024.156771_b0180 article-title: PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway publication-title: Cell Death Dis.. doi: 10.1038/s41419-023-05712-4 – volume: 160 start-page: 1381 year: 2002 ident: 10.1016/j.cyto.2024.156771_b0085 article-title: Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth publication-title: Am. J. Pathol.. doi: 10.1016/S0002-9440(10)62565-5 – volume: 107 start-page: 10 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0105 article-title: The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells publication-title: Exp Mol Pathol. doi: 10.1016/j.yexmp.2019.01.006 – volume: 18 start-page: 101 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0215 article-title: Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy publication-title: Mol Cancer. doi: 10.1186/s12943-019-1030-2 – volume: 7 start-page: 45 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0220 article-title: ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression publication-title: Sci Rep. doi: 10.1038/s41598-017-00079-x – volume: 13 start-page: 6590 year: 2022 ident: 10.1016/j.cyto.2024.156771_b0100 article-title: Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism publication-title: Bioengineered. doi: 10.1080/21655979.2022.2042141 – volume: 14 start-page: 1575 year: 2008 ident: 10.1016/j.cyto.2024.156771_b0045 article-title: Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer publication-title: World J. Gastroenterol.. doi: 10.3748/wjg.14.1575 – volume: 21 year: 2020 ident: 10.1016/j.cyto.2024.156771_b0235 article-title: Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy publication-title: Int J Mol Sci. doi: 10.3390/ijms21249651 – volume: 59 start-page: 125 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0145 article-title: PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside publication-title: Semin. Cancer Biol.. doi: 10.1016/j.semcancer.2019.07.009 – volume: 11 start-page: 5301 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0210 article-title: An emerging tumor invasion mechanism about the collective cell migration publication-title: Am. J. Transl. Res.. – volume: 120 start-page: 6026 year: 2019 ident: 10.1016/j.cyto.2024.156771_b0230 article-title: Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma publication-title: J Cell Biochem. doi: 10.1002/jcb.27889 – volume: 788 start-page: 341 year: 2013 ident: 10.1016/j.cyto.2024.156771_b0060 article-title: Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study publication-title: Adv. Exp. Med. Biol.. doi: 10.1007/978-94-007-6627-3_46 – volume: 19 start-page: 333 year: 2017 ident: 10.1016/j.cyto.2024.156771_b0135 article-title: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens publication-title: Neoplasia (new York, NY). doi: 10.1016/j.neo.2017.02.002 – volume: 141 start-page: 1117 year: 2010 ident: 10.1016/j.cyto.2024.156771_b0150 article-title: Cell signaling by receptor tyrosine kinases publication-title: Cell. doi: 10.1016/j.cell.2010.06.011 |
SSID | ssj0009377 |
Score | 2.4401703 |
Snippet | [Display omitted]
The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of... The impact of Ang-1 on tumors remains a subject of contention, with its mechanism of action exhibiting complexity in the progression of diverse tumor types.... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 156771 |
SubjectTerms | Akt/mTOR Ang-1 Angiopoietin-1 - metabolism Animals Antineoplastic Agents - pharmacology Artesunate Artesunate - pharmacology Artesunate - therapeutic use Carcinogenesis - drug effects Carcinogenesis - genetics Carcinogenesis - metabolism Carcinogenesis - pathology Cell Line, Tumor Cell Movement - drug effects Cell Proliferation - drug effects Choroidal melanoma Epithelial-mesenchymal transition Epithelial-Mesenchymal Transition - drug effects Female Humans Melanoma - drug therapy Melanoma - genetics Melanoma - metabolism Melanoma - pathology Mice Mice, Inbred BALB C Mice, Nude Proto-Oncogene Proteins c-akt - metabolism Signal Transduction - drug effects TOR Serine-Threonine Kinases - metabolism Xenograft Model Antitumor Assays |
Title | Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway |
URI | https://dx.doi.org/10.1016/j.cyto.2024.156771 https://www.ncbi.nlm.nih.gov/pubmed/39340959 https://www.proquest.com/docview/3110912507 |
Volume | 184 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhCXqi2vbWllJG4o3SR2kvVxtaJaWLVIpRW9WX7SQDdZ7WZBe-Fn8HuZiZMiDu2BU2THli3PZB7xNzOEvDXe53mhVCSsAwclS1ykXJJH3GubWND3ur0uODvPp1f843V2vUUmfSwMwio72R9keiutu55hd5rDRVkOP4MjwThY34iCTMHsxQh2XiCXn_z6C_MA9VuEjAQswtFd4EzAeJlNgwGAKT8BN6YokvuU033GZ6uETnfJTmc90nHY4B7ZctU-eRzqSW72yZOz7qb8Gfk9rr5GCV20aDu3os16jjWwULKVK6oqS9uYkfbVjYOOpowMcsCSdhAPWntcyK3WFQyjdUUnN_WyLi1sYO5uVVXPFf1Rqnb-MpS0ByK30743w_nlpwuK6BCFAe8UKx__VJvn5Or0_eVkGnU1GCLDsryJLBNeYNp1LmLFbJJ7AdLdZ946xRJmdVwIMzLQ8FmsPZw2s46lQrss9UJp9oJsV3XlXhFqrYmVSDOTa8e1FXoEnrDmdqRdwrThA5L0hy9Nl6Ac62Tcyh6J9k0iwSQSTAaCDci7uzmLkJ7jwdFZT1P5D5NJ0B8PznvTM4CErw-vVFTl6vVKMkzYCjZiXAzIy8AZd_tggnH8y3rwn6sekqfYCtiZ12S7Wa7dEVhAjT5uWfyYPBp_mE3P8Tm7-DL7A3LCCX0 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEY8LgvJaWsBI3FC6Sewk62O1olqgWyTYSr1ZfraBbrLazYL2ws_g93YmTlpxaA8cY3tkyzOeGcffzBDy3nif54VSkbAOLihZ4iLlkjziXtvEgr3X7XPB9DifnPDPp9npFhn3sTAIq-x0f9DprbbuWobdbg4XZTn8DhcJxsH7RhRkCm7vHXKXw_HFMgb7f65xHmB_i5CSgEU4vIucCSAvs2kwAjDl-3CPKYrkJut0k_fZWqHDx-RR5z7Sg7DCJ2TLVTvkXigoudkh96fdU_lT8vegOosSumjhdm5Fm_Uci2ChaitXVFWWtkEjbde5g4amjAyKwJJ2GA9ae5zIrdYVDKN1Rcfn9bIuLSxg7i5UVc8V_VWqln4ZatoDl1uyn81wPvv6jSI8RGHEO8XSx7_V5hk5Ofw4G0-irghDZFiWN5FlwgvMu85FrJhNci9AvfvMW6dYwqyOC2FGBj58FmsPu82sY6nQLku9UJo9J9tVXbmXhFprYiXSzOTacW2FHsFVWHM70i5h2vABSfrNl6bLUI6FMi5kD0X7IZFhEhkmA8MG5MMVzSLk57h1dNbzVP4jZRIMyK1073oBkHD88E1FVa5eryTDjK3gJMbFgLwIknG1DiYYx9-sr_5z1rfkwWQ2PZJHn46_7JKH2BOANHtku1mu3Wtwhxr9phX3SxwiCWg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ang-1+promotes+tumorigenesis+and+mediates+the+anti-cancer+effects+of+Artesunate+on+Choroidal+melanoma+via+the+regulation+of+Akt%2FmTOR+signaling+pathway&rft.jtitle=Cytokine+%28Philadelphia%2C+Pa.%29&rft.au=Yao%2C+Ningning&rft.au=Ma%2C+Qingyue&rft.au=Yi%2C+Wendan&rft.au=Liu%2C+Yichong&rft.date=2024-12-01&rft.issn=1096-0023&rft.eissn=1096-0023&rft.volume=184&rft.spage=156771&rft_id=info:doi/10.1016%2Fj.cyto.2024.156771&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-4666&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-4666&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-4666&client=summon |